TC
SGNT

TFS Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

TFS Capital’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-92,721
Closed -$1.39M – 1203
2016
Q2 		$1.39M Sell
92,721
-84,282
-48% -$1.08M 0.26% 86
2016
Q1 		$2.15M Buy
177,003
+29,738
+20% +$417K 0.31% 44
2015
Q4 		$2.34M Buy
147,265
+5,636
+4% +$88.7K 0.25% 125
2015
Q3 		$2.17M Sell
141,629
-5,017
-3% -$108K 0.21% 135
2015
Q2 		$3.56M Buy
146,646
+70,864
+94% +$1.7M 0.35% 60
2015
Q1 		$1.76M Sell
75,782
-48,294
-39% -$1.28M 0.17% 170
2014
Q4 		$3.12M Sell
124,076
-16,451
-12% -$483K 0.3% 86
2014
Q3 		$4.37M Buy
140,527
+111,996
+393% +$3.03M 0.38% 42
2014
Q2 		$738K Buy
28,531
+9,997
+54% +$222K 0.06% 515
2014
Q1 		$433K Sell
18,534
-2,544
-12% -$55.6K 0.03% 804
2013
Q4 		$535K Sell
21,078
-127,579
-86% -$2.88M 0.03% 797
2013
Q3 		$3.03M Buy
148,657
+86,392
+139% +$1.92M 0.14% 200
2013
Q2 		$1.31M Buy
+62,265
New +$1.11M 0.05% 493

TFS Capital's SGNT Position: Q3 2016 in Review

TFS Capital sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 92,721 shares — an estimated $1.39M sold.

TFS Capital first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $4.37M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • TFS Capital reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • TFS Capital sold 92,721 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $1.39M.
  • TFS Capital first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • TFS Capital's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $4.37M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.